APA (7th ed.) Citation

Zimmerman, Z., Maniar, T., & Nagorsen, D. (2015). Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE) antibody construct blinatumomab as a potential therapy. International immunology, 27(1), . https://doi.org/10.1093/intimm/dxu089

Chicago Style (17th ed.) Citation

Zimmerman, Zachary, Tapan Maniar, and Dirk Nagorsen. "Unleashing the Clinical Power of T Cells: CD19/CD3 Bi-specific T Cell Engager (BiTE) Antibody Construct Blinatumomab as a Potential Therapy." International Immunology 27, no. 1 (2015). https://doi.org/10.1093/intimm/dxu089.

MLA (9th ed.) Citation

Zimmerman, Zachary, et al. "Unleashing the Clinical Power of T Cells: CD19/CD3 Bi-specific T Cell Engager (BiTE) Antibody Construct Blinatumomab as a Potential Therapy." International Immunology, vol. 27, no. 1, 2015, https://doi.org/10.1093/intimm/dxu089.